150 related articles for article (PubMed ID: 21976948)
21. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.
Yoshida N; Hisatomi T; Ikeda Y; Kohno R; Murakami Y; Imaki H; Ueno A; Fujisawa K; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1547-52. PubMed ID: 21842129
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab for ocular metastasis of multiple myeloma.
Zhou Q; Liang J; Lu H
Optom Vis Sci; 2013 Sep; 90(9):e236-40; discussion 1028. PubMed ID: 23811608
[TBL] [Abstract][Full Text] [Related]
24. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
[TBL] [Abstract][Full Text] [Related]
25. Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma.
Bartz-Schmidt KU; Thumann G; Psichias A; Krieglstein GK; Heimann K
Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):969-75. PubMed ID: 10654165
[TBL] [Abstract][Full Text] [Related]
26. [Pseudohypopyon of cholesterol crystals occurring 16 years after retinal detachment in x-linked retinoschisis].
Mielke J; Freudenthaler N; Schlote T; Bartz-Schmidt KU
Klin Monbl Augenheilkd; 2001 Nov; 218(11):741-3. PubMed ID: 11731903
[TBL] [Abstract][Full Text] [Related]
27. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Fong AW; Lee GA; O'Rourke P; Thomas R
Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
[TBL] [Abstract][Full Text] [Related]
28. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
29. Intracameral bevacizumab for iris rubeosis.
Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
Sagong M; Kim J; Chang W
Korean J Ophthalmol; 2009 Sep; 23(3):215-8. PubMed ID: 19794952
[TBL] [Abstract][Full Text] [Related]
32. Anterior segment ischemia with rubeosis iridis after a circular buckling operation treated successfully with an intravitreal bevacizumab injection: a case report and review of the literature.
Janssens K; Zeyen T; Van Calster J
Bull Soc Belge Ophtalmol; 2012; (319):5-9. PubMed ID: 22550771
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
Eur J Ophthalmol; 2009; 19(4):607-12. PubMed ID: 19551676
[TBL] [Abstract][Full Text] [Related]
34. Comparison between the efficacy and side effects of intravitreal versus anterior chamber Bevacizumab injection in neovascular glaucoma patients.
Ungureanu E; Geamanu A; Popescu V; Dinu I; Grecescu M; Gradinaru S
J Med Life; 2014; 7 Spec No. 4(Spec Iss 4):68-70. PubMed ID: 27057252
[TBL] [Abstract][Full Text] [Related]
35. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
Ouhadj O; Chergui I; Mendil L; Nouri MT
J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
[TBL] [Abstract][Full Text] [Related]
36. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.
Falavarjani KG; Modarres M; Nazari H
Eye (Lond); 2010 Apr; 24(4):717-9. PubMed ID: 19407842
[TBL] [Abstract][Full Text] [Related]
38. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
39. [Management of neovascular glaucoma related to the persistence after retinal detachment surgery of a circumferential peripheral retinal detachment].
Delaunay-Suply AC; Cochener B; Gambrelle J
J Fr Ophtalmol; 2011 Dec; 34(10):711-4. PubMed ID: 21943796
[TBL] [Abstract][Full Text] [Related]
40. [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].
Lüke J; Lüke M; Grisanti S
Ophthalmologe; 2009 May; 106(5):407-12. PubMed ID: 19418055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
